Pomezia, Italy

Martina Tripepi

This inventor holds 1 USPTO granted patent and 1 published patent application and 3 EPO patents. Top assignee: Sanofi-Aventis Recherche & Développement. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martina Tripepi. Retrieved from https://idiyas.com/inventor/martina-tripepi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martina Tripepi - Innovator in Therapeutic Compounds

Introduction

Martina Tripepi is an accomplished inventor based in Pomezia, Italy. She is currently associated with Sanofi, a global healthcare company. Although she does not hold any granted patents, her contributions to the field of therapeutic compounds are noteworthy.

Latest Patent Applications

Martina's latest patent application is titled "CRF2 Receptor Agonists and Their Use in Therapy." This application provides compounds that are peptides comprising the amino acid sequence of the formula (I) disclosed herein or pharmaceutically acceptable salts thereof. The compounds act as agonists of the corticotropin-releasing factor receptor 2 (CRF2) and are useful in therapy, especially in the treatment or prevention of cardiovascular diseases, obesity, and diabetes.

Conclusion

Martina Tripepi's work in developing innovative therapeutic compounds highlights her commitment to advancing healthcare solutions. Her research has the potential to make significant impacts in the treatment of various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…